Monjuvi

Novartis Boosts Portfolio with Monjuvi Acquisition

📰 Novartis acquires MorphoSys, gaining access to Monjuvi for lymphoma treatment. 🤝 Strengthens portfolio, expands biotech presence. 😊 Incyte benefits from collaboration agreement. 💼 Reflects global biotech growth.